S-Nitrosoglutathione

S-Nitrosoglutathione

SCHEMBL1147641

N[C@H](CCC(=O)N[C@H](CSN=O)C(=O)NCC(=O)O)C(=O)O

nearest known ligand 0.67

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 1/20 0.67
GSTK1 Q9Y2Q3 1/20 0.67
GLO1 Q04760 4/20 0.59
NOD1 Q9Y239 5/20 0.41
FOLH1 Q04609 2/20 0.40
GRM8 O00222 1/20 0.38
GRM6 O15303 1/20 0.38
GRIN2D O15399 1/20 0.38
GRIN3B O60391 1/20 0.38
GSR P00390 1/20 0.38
CYP1A2 P05177 1/20 0.38
GRIK1 P39086 1/20 0.38
GRM5 P41594 1/20 0.38
GRIA1 P42261 1/20 0.38
GRIA2 P42262 1/20 0.38
GRIA3 P42263 1/20 0.38
SLC1A3 P43003 1/20 0.38
SLC1A2 P43004 1/20 0.38
SLC1A1 P43005 1/20 0.38
GRIA4 P48058 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
S-Nitrosoglutathione SCHEMBL154574 1.00 PTGS1 (0.67) PTGS1GSTK1GLO1NOD1FOLH1
S-Nitrosoglutathione SCHEMBL28090640 1.00 PTGS1 (0.67) PTGS1GSTK1GLO1NOD1FOLH1
S-Nitrosoglutathione SCHEMBL154575 1.00 PTGS1 (0.67) PTGS1GSTK1GLO1NOD1FOLH1
S-Nitrosoglutathione SCHEMBL30637209 1.00 PTGS1 (0.67) PTGS1GSTK1GLO1NOD1FOLH1
S-Nitrosoglutathione SCHEMBL17619393 1.00 PTGS1 (0.67) PTGS1GSTK1GLO1NOD1FOLH1
S-Nitrosoglutathione SCHEMBL28191391 0.99 PTGS1 (0.65) PTGS1GSTK1GLO1NOD1FOLH1
S-Nitrosoglutathione SCHEMBL28191352 0.99 PTGS1 (0.65) PTGS1GSTK1GLO1NOD1FOLH1
S-Nitrosoglutathione SCHEMBL29261007 0.99 PTGS1 (0.65) PTGS1GSTK1GLO1NOD1FOLH1
S-Nitrosoglutathione SCHEMBL6802668 0.98 PTGS1 (0.64) PTGS1GSTK1GLO1NOD1FOLH1
S-Nitrosoglutathione SCHEMBL3900254 0.96 PTGS1 (0.66) PTGS1GSTK1GLO1NOD1FOLH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 110 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118108543-A Lawn improving composition and lawn improving method 中国科学院植物研究所 2024-05-31 CN claimed
EP-2351828-B1 Methods and compositions for regulating biofilm development NEWSOUTH INNOVATIONS PTY LTD (AU) 2017-10-18 EP claimed
EP-1899451-B1 METHODS AND COMPOSITIONS FOR REGULATING BIOFILM DEVELOPMENT NEWSOUTH INNOVATIONS PTY LTD (AU) 2016-10-12 EP claimed
WO-2016065423-A1 METHOD AND COMPOSITIONS FOR PREVENTING BACTERIAL CORROSION OF A SUBSTRATE IXOM OPERATIONS PTY LTD (AU) 2016-05-06 WO claimed
US-20160089396-A1 METHODS AND COMPOSITIONS FOR REGULATING BIOFILM DEVELOPMENT NEWSOUTH INNOVATIONS PTY LIMITED (AU) 2016-03-31 US claimed
US-20130230606-A1 METHODS AND COMPOSITIONS FOR REGULATING BIOFILM DEVELOPMENT NEWSOUTH INNOVATIONS PTY LIMITED (AU) 2013-09-05 US claimed
US-8425945-B2 Methods and compositions for regulating biofilm development NEWSOUTH INNOVATIONS PTY LIMITED (AU) 2013-04-23 US claimed
EP-2351828-A1 Methods and compositions for regulating biofilm development Environmental Biotechnology CRC Pty Limited (AU) 2011-08-03 EP claimed
US-20090214674-A1 Methods and Compositions for Regulating Biofilm Development ENIVORNMENTAL BIOTECHNOLOGY CRC PTY LIMITED 2009-08-27 US claimed
EP-1899451-A4 METHODS AND COMPOSITIONS FOR REGULATING BIOFILM DEVELOPMENT ENVIRONMENTAL BIOTECHNOLOGY CR (AU) 2008-11-26 EP claimed
EP-1899451-A1 METHODS AND COMPOSITIONS FOR REGULATING BIOFILM DEVELOPMENT Environmental Biotechnology CRC Pty Limited (AU) 2008-03-19 EP claimed
WO-2007100910-A2 TRANSDERMAL PATCHES CONTAINING A NITRIC OXIDE-DONOR AND A SECOND ACTIVE AGENT AND ASSOCIATED METHODS CURE THERAPEUTICS, INC. (US) 2007-09-07 WO claimed
US-20070202155-A1 Low dose no donor-containing transdermal patch CURE THERAPEUTICS, INC. 2007-08-30 US claimed
WO-2007092284-A2 LOW DOSE NO DONOR-CONTAINING TRANSDERMAL PATCH CURE THERAPEUCTICS, INC. (US) 2007-08-16 WO claimed
US-20070059351-A1 Transdermal patches containing a nitric oxide-donor and a second active agent and associated methods CURE THERAPEUTICS, INC. 2007-03-15 US claimed
WO-2006125262-A1 METHODS AND COMPOSITIONS FOR REGULATING BIOFILM DEVELOPMENT ENVIRONMENTAL BIOTECHNOLOGY CRC PTY LIMITED (AU) 2006-11-30 WO claimed
WO-2005046660-A1 MODULATING SUBSTANCES OF THE NITRIC OXID (NO) - CYCLIC GUANOSINE - 3’,5’- MONOPHOSPHATE (cGMP) SIGNALING PATHWAY FOR THE TREATMENT OF DENTAL DISORDERS CELL CENTER COLOGNE GMBH (DE) 2005-05-26 WO claimed
US-20040197274-A1 Methods and apparatus for therapeutic treatment of respiratory, cardiac and other pathologies FEIN HARRY (US) 2004-10-07 US claimed
US-20020192163-A1 Methods and apparatus for therapeutic treatment of respiratory, cardiac and other pathologies WORLD PRECISION INSTRUMENTS, INC. 2002-12-19 US claimed
WO-2000051597-A1 METHODS FOR INHIBITING CATHEPSIN K ACTIVITY FOR THE TREATMENT OF DISEASES RELATED TO BONE LOSS MERCK FROSST CANADA & CO. (CA) 2000-09-08 WO claimed